USD 7.5
(-3.97%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 5.84 Million | 10.01 Million | 2.8 Million | 6.89 Million | -542.82 Thousand | 375.21 Thousand |
Net Income | 7.14 Million | 15.68 Million | 10.04 Million | 6.38 Million | 2.78 Million | 657.68 Thousand |
Depreciation & Amortization | 1.36 Million | 1.45 Million | 926.09 Thousand | 728.62 Thousand | 520.29 Thousand | 286.74 Thousand |
Deferred income taxes | 1.52 Million | -1.48 Million | - | -1.83 Million | - | - |
Stock-based compensation | - | - | - | 325.00 | - | - |
Change in working capital | -6.38 Million | -4.91 Million | -7.47 Million | -215.8 Thousand | -3.84 Million | -1.85 Million |
Other non-cash items | 9.5 Million | -718.09 Thousand | -697.37 Thousand | 1.83 Million | 5.02 Million | 1.28 Million |
Investing Cash Flow | -1.75 Million | -229.33 Thousand | -4.87 Million | -7.96 Million | -6.03 Million | -191.13 Thousand |
Investments in PPE | -2.23 Million | -272.74 Thousand | -3.13 Million | -5.86 Million | -162.98 Thousand | -191.13 Thousand |
Acquisitions | -100 Thousand | -216.98 Thousand | -1.49 Million | - | -5.87 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 578.25 Thousand | 260.39 Thousand | -238.64 Thousand | -2.1 Million | -60 Thousand | -66 Thousand |
Financing Cash Flow | -3.39 Million | -2.75 Million | 2.99 Million | 5.77 Million | 9.63 Million | -2352.00 |
Debt repayment | -1.24 Million | -2.75 Million | -481.59 Thousand | -305.32 Thousand | -510.94 Thousand | -2352.00 |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -2.15 Million | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -4.00 | -2.75 Million | 3.47 Million | 6.08 Million | 10.15 Million | - |
Accounts receivables | -161.81 Thousand | -903.79 Thousand | -3.96 Million | 151.12 Thousand | -1.87 Million | 115.02 Thousand |
Accounts payables | -32.31 Thousand | 1.36 Million | 752.37 Thousand | -29.33 Thousand | -3.56 Million | -976.98 Thousand |
Inventory | -4.39 Million | -4.7 Million | -3.55 Million | -497.44 Thousand | 1.46 Million | -1.16 Million |
Other working capital | -1.8 Million | -671.29 Thousand | -700.4 Thousand | 159.84 Thousand | 136.07 Thousand | 178.18 Thousand |
Cash at beginning of period | 17.16 Million | 10.13 Million | 9.21 Million | 4.51 Million | 1.45 Million | 1.27 Million |
Cash at end of period | 17.85 Million | 17.16 Million | 10.13 Million | 9.21 Million | 4.51 Million | 1.45 Million |
Capital Expenditure | -2.23 Million | -272.74 Thousand | -3.13 Million | -5.86 Million | -162.98 Thousand | -191.13 Thousand |
Effect of forex changes on cash | -5.84 Million | - | - | - | - | - |
Net cash flow / Change in cash | 683.88 Thousand | 7.03 Million | 920.11 Thousand | 4.7 Million | 3.05 Million | 181.73 Thousand |
Free Cash Flow | 3.6 Million | 9.74 Million | -333.65 Thousand | 1.03 Million | -705.81 Thousand | 184.08 Thousand |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.68 Million | 1.56 Million | 1.9 Million | 1.3 Million | 7.14 Million | 1.7 Million |
Depreciation & Amortization | 414.77 Thousand | 362.26 Thousand | 343.56 Thousand | 333.82 Thousand | 1.36 Million | 337.71 Thousand |
Deferred income taxes | 40.9 Thousand | -27.89 Thousand | -17.49 Thousand | 141.27 Thousand | 1.52 Million | 510.22 Thousand |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2.35 Million | -3.4 Million | 1.04 Million | -1.2 Million | -6.38 Million | -2.06 Million |
Other non-cash items | -1.04 Million | 3.68 Million | -117.15 Thousand | 1.47 Million | 9.5 Million | -2.04 Million |
Investing Cash Flow | -1.69 Million | -620.21 Thousand | -644.79 Thousand | -474.49 Thousand | -1.75 Million | -562.74 Thousand |
Investments in PPE | -1.69 Million | -620.61 Thousand | -641.4 Thousand | -674.49 Thousand | -2.23 Million | -262.74 Thousand |
Acquisitions | - | - | - | 200 Thousand | -100 Thousand | -300 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 2983.00 | 400.00 | -3383.00 | -2.33 Million | 578.25 Thousand | - |
Financing Cash Flow | -1.04 Million | -1.03 Million | -1.21 Million | -1.34 Million | -3.39 Million | -1.23 Million |
Debt repayment | -626.62 Thousand | -314.85 Thousand | -311.76 Thousand | -513.05 Thousand | -1.24 Million | -310.61 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | 1.62 Million | -715.33 Thousand | -905.14 Thousand | -836.69 Thousand | -2.15 Million | -1.12 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2.03 Million | - | -1.21 Million | -1.00 | -4.00 | 200 Thousand |
Accounts receivables | 936.01 Thousand | -435.46 Thousand | 3.16 Million | 1.22 Million | -161.81 Thousand | -1.3 Million |
Accounts payables | -503.61 Thousand | -652.97 Thousand | 621.06 Thousand | -138.38 Thousand | -32.31 Thousand | 561.91 Thousand |
Inventory | -2.29 Million | -1.15 Million | -2.47 Million | -95.32 Thousand | -4.39 Million | -1.53 Million |
Other working capital | 1.42 Million | -1.15 Million | -263.68 Thousand | -2.19 Million | -1.8 Million | 216.93 Thousand |
Cash at beginning of period | 17.34 Million | 19.78 Million | 17.85 Million | 17.3 Million | 17.16 Million | 18.38 Million |
Cash at end of period | 17.75 Million | 17.34 Million | 19.78 Million | 17.85 Million | 17.85 Million | 17.3 Million |
Capital Expenditure | -1.69 Million | -620.61 Thousand | -641.4 Thousand | -674.49 Thousand | -2.23 Million | -262.74 Thousand |
Effect of forex changes on cash | - | - | - | 46.14 Thousand | -5.84 Million | 3.12 Million |
Net cash flow / Change in cash | 408.19 Thousand | -2.43 Million | 1.93 Million | 548.46 Thousand | 683.88 Thousand | -1.07 Million |
Free Cash Flow | 1.75 Million | -1.41 Million | 3.15 Million | 1.69 Million | 3.6 Million | 458.76 Thousand |
RX
EZE
TSLVF
BIS
PRM
CESC